Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.

Halpern, M., Covert, D., & Robin, A. (2002). Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects. Transactions of the American Ophthalmological Society, 100, 109 - 118.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Development of a novel shared decision making aid for primary immunodeficiency diseases
Article

Community overdose surveillance
Article

Epigenetic biomarkers for smoking cessation